FDA Inspection 541807 — Sandoz Incorporated

Sandoz Incorporated — FEI 1717759

The FDA completed an inspection of Sandoz Incorporated on October 8, 2008 in East Hanover, NJ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
October 8, 2008
Fiscal Year
2009
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
East Hanover, NJ (United States)

Additional Details

Postmarket Adverse Drug Experience (PADE)

Citations

IDCFRDescription
673221 CFR 314.80(c)(1)(i)Late submission of 15-day report